21 years of historical data (2005–2025) · Technology · Information Technology Services
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Genpact Limited trades at 10.8x earnings, 42% below its 5-year average of 18.5x, sitting at the 5th percentile of its historical range. Compared to the Technology sector median P/E of 27.5x, the stock trades at a discount of 61%. On a free-cash-flow basis, the stock trades at 7.8x P/FCF, 51% below the 5-year average of 15.8x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $5.7B | $8.3B | $7.7B | $6.4B | $8.7B | $10.2B | $8.1B | $8.2B | $5.2B | $6.3B | $5.1B |
| Enterprise Value | $6.6B | $9.2B | $8.5B | $7.3B | $9.8B | $11.3B | $9.4B | $9.6B | $6.2B | $7.0B | $5.6B |
| P/E Ratio → | 10.80 | 14.95 | 15.07 | 10.18 | 24.64 | 27.79 | 26.34 | 27.03 | 18.61 | 23.69 | 19.02 |
| P/S Ratio | 1.13 | 1.63 | 1.63 | 1.44 | 1.99 | 2.55 | 2.18 | 2.34 | 1.74 | 2.29 | 1.99 |
| P/B Ratio | 2.34 | 3.24 | 3.24 | 2.86 | 4.77 | 5.40 | 4.41 | 4.87 | 1.06 | 4.38 | 3.96 |
| P/FCF | 7.81 | 11.25 | 14.62 | 14.87 | 22.38 | 16.08 | 15.77 | 25.79 | 29.23 | 21.91 | 19.90 |
| P/OCF | 7.06 | 10.17 | 12.59 | 13.09 | 19.64 | 14.75 | 13.87 | 19.23 | 15.42 | 17.42 | 14.79 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Genpact Limited's enterprise value stands at 7.8x EBITDA, 39% below its 5-year average of 12.7x. The Technology sector median is 17.4x, placing the stock at a 55% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.81 | 1.79 | 1.64 | 2.23 | 2.82 | 2.53 | 2.73 | 2.06 | 2.55 | 2.17 |
| EV / EBITDA | 7.78 | 10.73 | 10.71 | 10.00 | 15.46 | 16.77 | 15.71 | 17.20 | 13.66 | 16.34 | 13.21 |
| EV / EBIT | 8.75 | 11.77 | 11.30 | 10.99 | 18.66 | 20.95 | 20.59 | 21.32 | 15.03 | 19.32 | 15.83 |
| EV / FCF | — | 12.49 | 16.12 | 17.00 | 25.08 | 17.81 | 18.31 | 30.07 | 34.46 | 24.41 | 21.75 |
Margins and return-on-capital ratios measuring operating efficiency
Genpact Limited earns an operating margin of 15.0%. ROE of 22.4% indicates solid capital efficiency. ROIC of 17.2% represents solid returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 35.6% | 35.6% | 35.5% | 35.1% | 35.1% | 35.6% | 34.8% | 34.8% | 36.0% | 38.6% | 39.5% |
| Operating Margin | 15.0% | 15.0% | 14.7% | 14.1% | 11.5% | 12.7% | 11.8% | 12.2% | 11.6% | 12.1% | 13.3% |
| Net Profit Margin | 10.9% | 10.9% | 10.8% | 14.1% | 8.1% | 9.2% | 8.3% | 8.7% | 9.4% | 9.5% | 10.4% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 22.4% | 22.4% | 22.2% | 31.0% | 19.0% | 19.8% | 17.5% | 9.2% | 8.8% | 19.2% | 20.6% |
| ROA | 10.2% | 10.2% | 10.5% | 13.4% | 7.4% | 7.5% | 6.6% | 7.6% | 8.1% | 8.2% | 9.4% |
| ROIC | 17.2% | 17.2% | 16.6% | 15.7% | 12.8% | 12.4% | 10.6% | 7.2% | 6.5% | 12.7% | 15.0% |
| ROCE | 18.4% | 18.4% | 18.7% | 18.1% | 14.0% | 13.9% | 12.2% | 14.1% | 13.5% | 13.9% | 15.7% |
Solvency and debt-coverage ratios — lower is generally safer
Genpact Limited carries a Debt/EBITDA ratio of 2.1x, which is manageable (28% below the sector average of 2.9x). Net debt stands at $911M ($1.8B total debt minus $854M cash). Interest coverage of 15.7x signals virtually no risk of debt distress — earnings comfortably cover interest obligations.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.69 | 0.69 | 0.60 | 0.67 | 0.93 | 1.05 | 1.08 | 1.09 | 0.26 | 0.85 | 0.69 |
| Debt / EBITDA | 2.06 | 2.06 | 1.81 | 2.05 | 2.69 | 2.96 | 3.32 | 3.29 | 2.89 | 2.85 | 2.12 |
| Net Debt / Equity | — | 0.36 | 0.33 | 0.41 | 0.58 | 0.58 | 0.71 | 0.81 | 0.19 | 0.50 | 0.37 |
| Net Debt / EBITDA | 1.07 | 1.07 | 1.00 | 1.25 | 1.66 | 1.63 | 2.18 | 2.45 | 2.07 | 1.67 | 1.12 |
| Debt / FCF | — | 1.24 | 1.50 | 2.13 | 2.70 | 1.73 | 2.54 | 4.28 | 5.22 | 2.49 | 1.85 |
| Interest Coverage | 15.72 | 15.72 | 9.51 | 10.08 | 9.01 | 9.29 | 8.12 | 8.87 | 8.46 | 9.03 | 15.07 |
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.66x means Genpact Limited can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has improved from 1.44x to 1.66x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.66 | 1.66 | 2.16 | 1.44 | 1.61 | 1.47 | 1.45 | 1.70 | 1.39 | 1.71 | 1.68 |
| Quick Ratio | 1.66 | 1.66 | 2.16 | 1.44 | 1.61 | 1.47 | 1.45 | 1.70 | 1.23 | 1.48 | 1.44 |
| Cash Ratio | 0.75 | 0.75 | 0.70 | 0.44 | 0.59 | 0.69 | 0.57 | 0.51 | 0.38 | 0.60 | 0.58 |
| Asset Turnover | — | 0.87 | 0.96 | 0.93 | 0.95 | 0.81 | 0.76 | 0.79 | 0.85 | 0.79 | 0.89 |
| Inventory Turnover | — | — | — | — | — | — | — | — | 12.79 | 8.78 | 9.01 |
| Days Sales Outstanding | — | 91.93 | 94.27 | 92.43 | 84.03 | 81.33 | 87.58 | 96.77 | 96.90 | 92.43 | 87.36 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Genpact Limited returns 6.9% to shareholders annually — split between a 2.0% dividend yield and 4.9% buyback yield. The payout ratio of 21.3% is conservative, leaving significant room for dividend growth or reinvestment. The earnings yield of 9.3% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 2.0% | 1.4% | 1.4% | 1.6% | 1.1% | 0.8% | 0.9% | 0.8% | 1.1% | 0.7% | — |
| Payout Ratio | 21.3% | 21.3% | 21.1% | 15.8% | 26.0% | 21.8% | 24.1% | 21.2% | 20.3% | 17.9% | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 9.3% | 6.7% | 6.6% | 9.8% | 4.1% | 3.6% | 3.8% | 3.7% | 5.4% | 4.2% | 5.3% |
| FCF Yield | 12.8% | 8.9% | 6.8% | 6.7% | 4.5% | 6.2% | 6.3% | 3.9% | 3.4% | 4.6% | 5.0% |
| Buyback Yield | 4.9% | 3.4% | 3.3% | 3.5% | 2.5% | 2.9% | 1.7% | 0.4% | 2.9% | 3.5% | 6.7% |
| Total Shareholder Yield | 6.9% | 4.9% | 4.7% | 5.1% | 3.5% | 3.7% | 2.6% | 1.2% | 4.0% | 4.3% | 6.7% |
| Shares Outstanding | — | $177M | $180M | $185M | $188M | $193M | $196M | $195M | $194M | $197M | $210M |
Compare G with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $6B | 10.8 | 7.8 | 7.8 | 35.6% | 15.0% | 22.4% | 17.2% | 2.1 | |
| $5B | 20.1 | 13.7 | 16.2 | 38.4% | 15.0% | 27.2% | 20.4% | 1.1 | |
| $6B | 13.6 | 7.1 | 11.2 | 30.7% | 11.5% | 12.8% | 19.8% | 0.2 | |
| $24B | 11.3 | 5.9 | 9.4 | 33.7% | 16.7% | 15.2% | 18.7% | 0.4 | |
| $21B | 15.1 | 11.3 | 12.9 | 30.7% | 17.0% | 16.8% | 13.4% | 1.1 | |
| $109B | 14.4 | 8.3 | 10.0 | 31.9% | 14.7% | 25.0% | 26.8% | 0.6 | |
| $212B | 20.2 | 17.3 | 18.3 | 59.5% | 15.3% | 35.2% | 9.8% | 4.4 | |
| $51B | 16.6 | 10.6 | 12.5 | 30.5% | 21.1% | 28.9% | 31.8% | 0.2 | |
| $145M | -0.7 | — | — | — | -5.5% | -96.5% | -7.6% | — | |
| $202B | 24.6 | 15.4 | 21.7 | 73.8% | 26.7% | 15.5% | 16.0% | 0.7 | |
| $558B | 44.7 | 27.3 | — | 70.5% | 30.8% | 82.4% | 12.8% | 4.4 | |
| Technology Median | — | 27.5 | 17.4 | 19.8 | 48.6% | -0.5% | 2.4% | 2.9% | 2.9 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 21 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs ExlService Holdings, Inc..
Start ComparisonQuick answers to the most common questions about buying G stock.
Genpact Limited's current P/E ratio is 10.8x. The historical average is 26.4x. This places it at the 5th percentile of its historical range.
Genpact Limited's current EV/EBITDA is 7.8x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 13.1x.
Genpact Limited's return on equity (ROE) is 22.4%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 15.2%.
Based on historical data, Genpact Limited is trading at a P/E of 10.8x. This is at the 5th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Genpact Limited's current dividend yield is 1.97% with a payout ratio of 21.3%.
Genpact Limited has 35.6% gross margin and 15.0% operating margin. Operating margin between 10-20% is typical for established companies.
Genpact Limited's Debt/EBITDA ratio is 2.1x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.